C4 THERAPEUTICS INC. - COMMON STOCK
4.2500
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.2400
+5.99%
Today's range
3.9100 - 4.3385
ISIN
N/A
Source
NASDAQ
-
C4 Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
04 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
19 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
23 Feb 2023 07:00:02 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Two Virtual February 2023 Conferences
08 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
-
30 Jan 2023 07:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 07:00:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
03 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022
26 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
04 Aug 2022 08:00:03 By Nasdaq GlobeNewswire
-
02 Aug 2022 08:00:03 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
05 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
08 Apr 2022 13:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
16 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
09 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
08 Mar 2022 16:30:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Full Year 2021 Financial Results and Recent Business Highlights
24 Feb 2022 07:00:03 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio
10 Jan 2022 07:00:02 By Nasdaq GlobeNewswire